Our Mission
To improve patients’ lives through the discovery, development and delivery of therapeutics that leverage polymer science and other novel approaches.
VELTASSA® (patiromer) for oral suspension
First commercialized medicine resulting from Relypsa’s polymer technology platform. Important Safety Information
Vifor Pharma
As of September 1, 2016, Relypsa became a Vifor Pharma company. Learn more about Vifor Pharma.